BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7909964)

  • 1. Vascular amine oxidase activities during synergistic vasculotoxicity.
    Trent MB; Boor PJ
    Toxicology; 1994 Mar; 89(1):67-77. PubMed ID: 7909964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allylamine and beta-aminopropionitrile-induced vascular injury: an in vivo and in vitro study.
    Kumar D; Hysmith RM; Boor PJ
    Toxicol Appl Pharmacol; 1990 Apr; 103(2):288-302. PubMed ID: 2330590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allylamine and beta-aminopropionitrile induced aortic medial necrosis: mechanisms of synergism.
    Kumar D; Trent MB; Boor PJ
    Toxicology; 1998 Feb; 125(2-3):107-15. PubMed ID: 9570326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
    Conklin DJ; Trent MB; Boor PJ
    Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
    Langford SD; Trent MB; Balakumaran A; Boor PJ
    Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allylamine and beta-aminopropionitrile-induced vascular injury: enhanced expression of high-molecular-weight proteins.
    Awasthi S; Boor PJ
    J Toxicol Environ Health A; 1998 Jan; 53(1):61-76. PubMed ID: 9447229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine.
    Awasthi S; Boor PJ
    Toxicol Lett; 1993 Feb; 66(2):157-63. PubMed ID: 8430435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of semicarbazide and beta-aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat.
    Mercier N; Kakou A; Challande P; Lacolley P; Osborne-Pellegrin M
    Toxicol Appl Pharmacol; 2009 Sep; 239(3):258-67. PubMed ID: 19524603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amine metabolism: a novel path to coronary artery vasospasm.
    Conklin DJ; Boyce CL; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 2001 Sep; 175(2):149-59. PubMed ID: 11543647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
    Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications of arterial phenotype in response to amine oxidase inhibition by semicarbazide.
    Mercier N; El Hadri K; Osborne-Pellegrin M; Nehme J; Perret C; Labat C; Regnault V; Lamazière JM; Challande P; Lacolley P; Fève B
    Hypertension; 2007 Jul; 50(1):234-41. PubMed ID: 17452500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells.
    Manasieva V; Thakur S; Lione LA; Patel J; Baydoun A; Skamarauskas J
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of tresperimus by rat aorta semicarbazide-sensitive amine oxidase (SSAO).
    Claud P; Artur Y; Guichard JP; Laine R
    Fundam Clin Pharmacol; 2002 Dec; 16(6):461-70. PubMed ID: 12685504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro.
    He N; Singhal SS; Awasthi S; Zhao T; Boor PJ
    Toxicol Appl Pharmacol; 1999 Jul; 158(2):177-85. PubMed ID: 10406932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta.
    Lyles GA; Singh I
    J Pharm Pharmacol; 1985 Sep; 37(9):637-43. PubMed ID: 2867184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of semicarbazide-sensitive amine oxidase inhibitors on morphology of aorta and kidney in diabetic rats.
    Li C; Wang Z; Li X; Chen J
    BMC Endocr Disord; 2019 Jun; 19(1):59. PubMed ID: 31182088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
    Pino R; Lyles GA
    Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the behaviour of semicarbazide-sensitive amine oxidase in Sprague-Dawley rats treated with the monoamine oxidase inhibitor tranylcypromine.
    Fitzgerald DH; Tipton KF; Lyles GA
    J Neural Transm Suppl; 1998; 52():259-64. PubMed ID: 9564625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoacetone metabolism by semicarbazide-sensitive amine oxidase in rat aorta.
    Lyles GA; Chalmers J
    Biochem Pharmacol; 1995 Jan; 49(3):416-9. PubMed ID: 7857329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.